How Do We Identify Science's Most Worthwhile Problems?

years, physicist Alvin M. Weinberg--former director of the Oak Ridge National Laboratory and now Distinguished Fellow at Oak Ridge Associated Universities--has gained international acclaim not only for his scientific achievements, but also as a profound thinker, author, and social commentator. For his contributions to the development of nuclear energy, he has been the recipient of numerous honors, including the Enrico Fermi Award, the Harvey Prize, and the Atoms for Peace Award. From 1958 t

Written byAlvin Weinberg
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

For his contributions to the development of nuclear energy, he has been the recipient of numerous honors, including the Enrico Fermi Award, the Harvey Prize, and the Atoms for Peace Award. From 1958 to 1961, he served the United States government as a member of the President's Science Advisory Committee, and in 1974 he was White House director of energy research and development. Weinberg, now 78, is the author of seven books. The most recent, a collection of his writings titled Nuclear Reactions: Science and Trans-Science, published late last year by AIP Press in New York, covers a wide range of subjects pertinent to the inner workings of the science community and its complex relationship to the world at large.

The following excerpt draws upon two essays from that book, one written in 1970, the other in 1984. Weinberg urges the reader of this excerpt to consider--in addition to his ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies